Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example (PLoS ONE (2014) 9, 5 (e96316) DOI: 10.1371/journal.pone.0096316)

M. Burotto; J. Wilkerson; W. Stein; R. Motzer; S. Bates

doi:10.1371/journal.pone.0105179

Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example (PLoS ONE (2014) 9, 5 (e96316) DOI: 10.1371/journal.pone.0096316)

M. Burotto
, J. Wilkerson
, W. Stein
, R. Motzer
, S. Bates

Alexander Silberman Institute of Life Sciences

Research output: Contribution to journal › Comment/debate

Original language	English
Article number	e105179
Journal	PLoS ONE
Volume	9
Issue number	7
DOIs	https://doi.org/10.1371/journal.pone.0105179
State	Published - 31 Jul 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1371/journal.pone.0105179

Cite this

@article{b92392303748475d881d336458146e85,

title = "Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example (PLoS ONE (2014) 9, 5 (e96316) DOI: 10.1371/journal.pone.0096316)",

author = "M. Burotto and J. Wilkerson and W. Stein and R. Motzer and S. Bates",

year = "2014",

month = jul,

day = "31",

doi = "10.1371/journal.pone.0105179",

language = "אנגלית",

volume = "9",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "7",

}

TY - JOUR

T1 - Correction

T2 - Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example (PLoS ONE (2014) 9, 5 (e96316) DOI: 10.1371/journal.pone.0096316)

AU - Burotto, M.

AU - Wilkerson, J.

AU - Stein, W.

AU - Motzer, R.

AU - Bates, S.

PY - 2014/7/31

Y1 - 2014/7/31

UR - https://www.scopus.com/pages/publications/84905281774

U2 - 10.1371/journal.pone.0105179

DO - 10.1371/journal.pone.0105179

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

AN - SCOPUS:84905281774

SN - 1932-6203

VL - 9

JO - PLoS ONE

JF - PLoS ONE

IS - 7

M1 - e105179

ER -

Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example (PLoS ONE (2014) 9, 5 (e96316) DOI: 10.1371/journal.pone.0096316)

UN SDGs

Access to Document

Other files and links

Cite this